823 related articles for article (PubMed ID: 12514169)
1. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
Inohara N; Ogura Y; Fontalba A; Gutierrez O; Pons F; Crespo J; Fukase K; Inamura S; Kusumoto S; Hashimoto M; Foster SJ; Moran AP; Fernandez-Luna JL; Nuñez G
J Biol Chem; 2003 Feb; 278(8):5509-12. PubMed ID: 12514169
[TBL] [Abstract][Full Text] [Related]
2. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
Girardin SE; Boneca IG; Viala J; Chamaillard M; Labigne A; Thomas G; Philpott DJ; Sansonetti PJ
J Biol Chem; 2003 Mar; 278(11):8869-72. PubMed ID: 12527755
[TBL] [Abstract][Full Text] [Related]
3. The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
Netea MG; Ferwerda G; de Jong DJ; Werts C; Boneca IG; Jéhanno M; Van Der Meer JW; Mengin-Lecreulx D; Sansonetti PJ; Philpott DJ; Dharancy S; Girardin SE
J Biol Chem; 2005 Oct; 280(43):35859-67. PubMed ID: 16115863
[TBL] [Abstract][Full Text] [Related]
4. Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease.
van Heel DA; Hunt KA; King K; Ghosh S; Gabe SM; Mathew CG; Forbes A; Playford RJ
Inflamm Bowel Dis; 2006 Jul; 12(7):598-605. PubMed ID: 16804397
[TBL] [Abstract][Full Text] [Related]
5. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.
Netea MG; Ferwerda G; de Jong DJ; Girardin SE; Kullberg BJ; van der Meer JW
Neth J Med; 2005 Sep; 63(8):305-8. PubMed ID: 16186640
[TBL] [Abstract][Full Text] [Related]
6. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition.
Tanabe T; Chamaillard M; Ogura Y; Zhu L; Qiu S; Masumoto J; Ghosh P; Moran A; Predergast MM; Tromp G; Williams CJ; Inohara N; Núñez G
EMBO J; 2004 Apr; 23(7):1587-97. PubMed ID: 15044951
[TBL] [Abstract][Full Text] [Related]
7. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
[TBL] [Abstract][Full Text] [Related]
8. Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity.
Rubino SJ; Magalhaes JG; Philpott D; Bahr GM; Blanot D; Girardin SE
Innate Immun; 2013 Oct; 19(5):493-503. PubMed ID: 23339926
[TBL] [Abstract][Full Text] [Related]
9. Gut microbial DL-endopeptidase alleviates Crohn's disease via the NOD2 pathway.
Gao J; Zhao X; Hu S; Huang Z; Hu M; Jin S; Lu B; Sun K; Wang Z; Fu J; Weersma RK; He X; Zhou H
Cell Host Microbe; 2022 Oct; 30(10):1435-1449.e9. PubMed ID: 36049483
[TBL] [Abstract][Full Text] [Related]
10. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
[TBL] [Abstract][Full Text] [Related]
11. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
[TBL] [Abstract][Full Text] [Related]
12. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
[TBL] [Abstract][Full Text] [Related]
13. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition.
Barnich N; Aguirre JE; Reinecker HC; Xavier R; Podolsky DK
J Cell Biol; 2005 Jul; 170(1):21-6. PubMed ID: 15998797
[TBL] [Abstract][Full Text] [Related]
14. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
15. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
Philpott DJ; Viala J
Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
[TBL] [Abstract][Full Text] [Related]
16. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA
J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783
[TBL] [Abstract][Full Text] [Related]
17. Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.
Salem M; Seidelin JB; Rogler G; Nielsen OH
Cell Mol Life Sci; 2013 Sep; 70(18):3391-404. PubMed ID: 23275943
[TBL] [Abstract][Full Text] [Related]
18. Further Insights on Structural Modifications of Muramyl Dipeptides to Study the Human NOD2 Stimulating Activity.
Cheng WC; You TY; Teo ZZ; Sayyad AA; Maharana J; Guo CW; Liang PH; Lin CS; Meng FC
Chem Asian J; 2020 Nov; 15(22):3836-3844. PubMed ID: 32975372
[TBL] [Abstract][Full Text] [Related]
19. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2.
Voss E; Wehkamp J; Wehkamp K; Stange EF; Schröder JM; Harder J
J Biol Chem; 2006 Jan; 281(4):2005-11. PubMed ID: 16319062
[TBL] [Abstract][Full Text] [Related]
20. Peptidoglycan Metabolite Photoaffinity Reporters Reveal Direct Binding to Intracellular Pattern Recognition Receptors and Arf GTPases.
Wang YC; Westcott NP; Griffin ME; Hang HC
ACS Chem Biol; 2019 Mar; 14(3):405-414. PubMed ID: 30735346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
